4FOC | Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 2 | date | 2012-06-20 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Whittington, D.A., Epstein, L.F., Chen, H. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.70 | ||||||||||||
ligand | 0UU | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | The discovery and optimization of a novel class of potent, selective and orally bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with potential utility for the treatment of cancer., Lewis RT, Bode CM, Choquette D, Potashman M, Romero K, Stellwagen JC, Teffera Y, Moore E, Whittington DA, Chen H, Epstein LF, Emkey R, Andrews PS, Yu V, Saffran DC, Xu M, Drew AE, Merkel P, Szilvassy S, Brake RL, J Med Chem. 2012 Jun 26. PMID:22734674 |
Data retrieval |
View 4FOC in 3D |
Visual 3D analysis of 4FOC |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4FOC |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |